文献速递生殖医学

高龄父亲年龄影响卵子捐赠周期中的流产与活产结局

Advanced paternal age affects miscarriages and live birth outcomes in oocyte donation cycles.
PubMed 文献 · Hum Reprod · 2026-10-06

结果显示父亲年龄>45岁者流产率显著升高(25.4% vs 15.6%),活产率显著降低(34.3% vs 42.4%),调整后仍显著。

要点

  • 父亲年龄>45岁与卵子捐赠周期首次移植后流产率升高独立相关。
  • 父亲年龄>45岁与活产率降低独立相关,且后续移植活产概率亦较低。
  • 父亲年龄作为连续变量呈渐进累积效应,无明显特定年龄拐点。

核心结论

  • 父亲年龄对卵子捐赠周期结局有渐进累积效应,超过45岁后流产率明显增加、活产率明显降低。

主要发现

  • 父亲年龄>45岁组流产率为25.4%(67/264),≤45岁组为15.6%(81/518),差异有统计学意义(P=0.001)。
  • 父亲年龄>45岁组活产率为34.3%(197/575),≤45岁组为42.4%(437/1031),差异有统计学意义(P=0.001)。
  • 调整后父亲年龄>45岁仍与更高流产率(aOR=1.86,95%CI 1.25-2.76,P=0.002)和更低活产率(aOR=0.72,95%CI 0.57-0.91,P=0.005)独立相关。
  • 探索性分析显示>45岁组后续胚胎移植获得活产的概率也较低(P=0.003)。
  • 父亲年龄>45岁组与<35岁组比较,活产比值比呈降低趋势(aOR=0.66;95%CI 0.43-1.02;P=0.06)。

临床怎么用

  • 对接受卵子捐赠且男方年龄>45岁的夫妇,应告知其流产风险升高和活产率降低的可能性。
  • 在延迟生育咨询中,可将男方年龄作为影响辅助生殖结局的因素之一进行讨论。

局限性

  • 研究为回顾性设计。
  • 缺乏移植囊胚的染色体状态数据。
  • 结果推广至不同胚胎移植策略或其他患者人群时需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Does advanced paternal age affect miscarriage and/or live birth outcomes following the first transfer attempt in oocyte donation cycles? SUMMARY ANSWER: Paternal age has a gradual but cumulative effect that becomes apparent above 45 years of age, where it evidently increases miscarriage rates and decreases live birth rates following the first transfer in oocyte donation cycles. WHAT IS ALREADY KNOWN: Donor oocyte cycles are becoming a common strategy for addressing female age-related infertility, offering high success rates (∼60% ongoing pregnancies) attributed to superior oocyte quality. However, male age-related effects on the success of ART have received less attention. In autologous cycles, advanced paternal age has been associated with poor clinical outcomes. However, disentangling its effects from female factors remains challenging. Oocyte donation cycles offer a useful model for studying the impact of male factors on ART outcomes, eliminating biases related to female age and underlying diagnoses. STUDY DESIGN, SIZE, DURATION: Multicentric, retrospective study of 1606 first oocyte donation cycles performed between January 2019 and December 2023, across seven IVF centers. Only ICSI cycles with fresh donor oocytes, inseminated with partner sperm were included. Only the first single blastocyst transfers (fresh or frozen) were considered. Cycles with abnormal male karyotypes, sperm obtained from testicular biopsy, donor sperm, frozen oocytes, in vitro matured oocytes or preimplantation genetic testing (PGT) were excluded. PARTICIPANTS/MATERIALS, SETTING, METHODS: Paternal age was assessed as a continuous variable, in multiple age strata (<35, 35-40, 40-45, and >45 years) and dichotomized into ≤45 and >45 years. Fertilization rates, the number of usable blastocysts and blastocyst utilization rates were assessed. Clinical outcomes included clinical pregnancy, miscarriage, and live birth rates. P < 0.05 was considered statistically significant after univariate tests and a multivariable logistic analysis adjusting for recipient and oocyte age, male and recipient BMI, fresh/frozen semen for insemination, number of mature (MII) oocytes injected, embryo morphology grade, and fresh/frozen embryo transfer. An exploratory analysis comparing Kaplan-Meier curves for subsequent embryo transfers was performed. MAIN RESULTS AND THE ROLE OF CHANCE: Within the cohort of 1606 patients who underwent a first oocyte donation cycle, the mean female recipient age (±SD) was 43.2 (±4.1) years, the mean oocyte donor age (±SD) was 26.2 (±4.2) years, and the mean paternal age (±SD) was 43.1 (±6.0). Paternal age as a continuous variable showed a modest but gradual reduction in live birth without a discrete transition at any specific age. Stratifying paternal age (<35, 35-40, 40-45, and >45 years) showed a trend to reduced odds of live birth when comparing the >45 years group to the <35 years group (aOR = 0.66; 95% CI 0.43-1.02; P = 0.06). To explore cumulative effects of paternal age in ART outcomes, we decided to compare in more detail two groups: ≤45 and >45 years. In the ≤45 years group (n = 1031), the mean paternal age (±SD) was 39.7 (±4.1) years, while in the >45 years group (n = 575), it was 49.1 (±3.7). No differences were observed in oocyte donor age, number of oocytes fertilized, or number of blastocysts obtained among paternal age groups. Interestingly, miscarriage rate was 25.4% (67/264) in the >45 years group and 15.6% (81/518) in the ≤45 years group. The differences were statistically significant (P = 0.001). Consequently, the live birth rate was also reduced to 34.3% in >45 years versus 42.4% in ≤45 years (197/575 vs 437/1031; P = 0.001). These results were further confirmed in the adjusted analysis, where >45 years of paternal age remained associated with a statistically significant higher miscarriage rate (aOR = 1.86, [95% CI: 1.25-2.76], P = 0.002) and a statistically significant lower live birth rate (aOR = 0.72, [95% CI: 0.57-0.91], P = 0.005). In an exploratory analysis, the >45 years group also showed a lower probability of achieving a live birth in subsequent embryo transfers compared to the ≤45 years old group (P = 0.003). LIMITATIONS, REASONS FOR CAUTION: This study is limited by its retrospective nature. No data on the chromosomal status of the blastocysts transferred was available. Caution is warranted when generalizing results to different embryo transfer strategies or other patient populations. WIDER IMPLICATIONS OF THE FINDINGS: Our results indicate that paternal age can affect clinical outcomes in oocyte donation cycles. If confirmed in a larger cohort of patients, these results would suggest considering patient counseling in relation to advanced paternal age when delaying childbearing. FUNDING: No funding was received from agencies in the public, commercial, or not-for-profit sectors. DISCLOSURES: The authors declare no conflict of interest related to the current study. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Fraire-Zamora JJ, Guglielmo MC, Bartoli E, et al. Advanced paternal age affects miscarriages and live birth outcomes in oocyte donation cycles. Hum Reprod. 2026. PMID: 42838517. doi:10.1093/humrep/deag159

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。